![Thomas Feldthus](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Feldthus
Chief Executive Officer at
SANA AB
Net worth: 2 M $ as of 31/05/2026
Profile
Thomas Feldthus was the founder of Servier Symphogen A, founded in 2000, serving as Chief Financial Officer from 2000 to 2012.
Mr. Feldthus is the founder of Aniona ApS, founded in 2012, serving as Director since 2012.
Mr. Feldthus is the founder of Saniona AB, founded in 2011, serving as Chief Executive Officer since 2022.
Mr. Feldthus was the founder of Scandion Oncology A, founded in 2017, serving as Director.
Mr. Feldthus is also the founder of Leukotech A,Ataxion, Inc.,Initiator Pharma A..
Mr. Feldthus is currently Chief Executive Officer & Director at Fertilizer Invest ApS.
Mr. Feldthus is currently Chairman at Rehaler ApS.
Mr. Feldthus is currently Chief Financial Officer & Director at Saniona A. Mr. Feldthus is currently Director at ResoTher Pharma AS.
Mr. Feldthus is currently Director at Synklino A. Former positions include Director-Business Development at Cheminova A, Manager-Corporate Development at Novo Nordisk A from 1996 to 1999, Investment Associate at Novo Holdings A, Investment Manager at Novo Ventures 1 A, and Chief Financial Officer at Wntresearch AB from 2012 to 2015.
Education includes graduate degrees from the University of London and the Technical University of Denmark, and an MBA from London Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SANIONA AB 1.01% | 31/12/2024 | 14,00,000 ( 1.01% ) | 2 M $ | 31/05/2026 |
Thomas Feldthus active positions
| Companies | Position | Start |
|---|---|---|
| SANA AB | Chief Executive Officer | 30/04/2022 |
Saniona A/S
 Saniona A/S Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on natural sciences and engineering | Director of Finance/CFO | - |
Synklino A/S
 Synklino A/S BiotechnologyHealth Technology Develops CMV-specific immunotoxin intended to eradicate the cytomegalovirus infections | Director/Board Member | - |
Rehaler ApS
 Rehaler ApS Medical SpecialtiesHealth Technology Develops medical devices for the treatment of migraine | Chairman | - |
ResoTher Pharma AS
 ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops peptide-based drugs | Director/Board Member | - |
Fertilizer Invest ApS | Chief Executive Officer | - |
Aniona ApS
 Aniona ApS Medical/Nursing ServicesHealth Services Aniona ApS is a private company based in Ballerup, Denmark. Jørgen Drejer has been the CEOs since incorporation. The Danish company was founded by Thomas Feldthus, Anker Gunvald Lundemose, Claus Tycho Bræstrup, Jørgen Drejer. | Founder | 01/09/2012 |
Former positions of Thomas Feldthus
| Companies | Position | End |
|---|---|---|
| WNTRESEARCH AB | Director of Finance/CFO | 01/06/2015 |
Symphogen A/S
 Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Founder | 02/04/2012 |
| ░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░ | - |
| ░░░░ ░░░░░░░░ ░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Thomas Feldthus
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
43
1st degree connections
20
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 20 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Novo Holdings A/S (Denmark)
 Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager | Finance |
Cheminova A/S
 Cheminova A/S Chemicals: AgriculturalProcess Industries Manufactures pesticides and other agrochemical products | Process Industries |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Technical University of Denmark
 Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London Business School
 London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leukotech A/S
 Leukotech A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures invests in companies located in Europe, the United States and Asia. The firm targets companies operating in the fields of health technology, health services, biotechnology and medical specialties sectors. It provides financing for early stage capital requirements. | Finance |
Wntresearch AB
 Wntresearch AB Pharmaceuticals: OtherHealth Technology Develops novel anti-metastatic therapies based synthetic peptides | Health Technology |
Aniona ApS
Aniona ApS Medical/Nursing ServicesHealth Services Aniona ApS is a private company based in Ballerup, Denmark. Jørgen Drejer has been the CEOs since incorporation. The Danish company was founded by Thomas Feldthus, Anker Gunvald Lundemose, Claus Tycho Bræstrup, Jørgen Drejer. | Health Services |
Saniona AB
 Saniona AB BiotechnologyHealth Technology Engages in the research and development of drugs to treat the central nervous system diseases | Health Technology |
Fertilizer Invest ApS | |
Ataxion, Inc.
 Ataxion, Inc. BiotechnologyHealth Technology Develops novel therapies for rare, debilitating, and underserved neurologic diseases | Health Technology |
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on natural sciences and engineering | Commercial Services |
Initiator Pharma A/S
 Initiator Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs to unmet medical needs within the central & peripheral nervous system | Health Technology |
ResoTher Pharma AS
ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops peptide-based drugs | Health Technology |
Scandion Oncology A/S
 Scandion Oncology A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for chemotherapy resistance mechanisms | Health Technology |
Rehaler ApS
Rehaler ApS Medical SpecialtiesHealth Technology Develops medical devices for the treatment of migraine | Health Technology |
Synklino A/S
Synklino A/S BiotechnologyHealth Technology Develops CMV-specific immunotoxin intended to eradicate the cytomegalovirus infections | Health Technology |
- Stock Market
- Insiders
- Thomas Feldthus
